- Report
- November 2023
- 88 Pages
Asia Pacific
From €3071EUR$3,450USD£2,657GBP
- Report
- November 2023
- 91 Pages
Europe
From €3071EUR$3,450USD£2,657GBP
- Report
- November 2023
- 74 Pages
From €2626EUR$2,950USD£2,272GBP
- Report
- November 2023
- 82 Pages
North America
From €2626EUR$2,950USD£2,272GBP
- Report
- August 2023
- 180 Pages
Global
From €3338EUR$3,750USD£2,889GBP
- Training
- 35 Hours
Global
€3622EUR$4,070USD£3,135GBP
- Report
- August 2023
- 98 Pages
Global
From €3500EUR$4,213USD£3,135GBP
- Report
- March 2022
- 98 Pages
Global
From €3500EUR$4,213USD£3,135GBP
- Report
- October 2022
- 94 Pages
Global
From €1780EUR$2,000USD£1,541GBP
- Book
- June 2018
- 368 Pages
- Book
- November 2019
United States
The Drug Screening market is an important part of the Drug Discovery process. It involves the use of high-throughput screening (HTS) technologies to identify potential drug candidates from a large library of compounds. HTS technologies allow for the rapid screening of thousands of compounds in a short period of time, making it an efficient and cost-effective way to identify potential drug candidates.
The Drug Screening market is highly competitive, with a number of companies offering a variety of HTS technologies. Companies in the market include Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, Thermo Fisher Scientific, and Promega Corporation. These companies provide a range of products and services, including automated liquid handling systems, cell-based assays, and high-content imaging systems. Show Less Read more
